December 6, 2017
GNS561 Gets US FDA IND Approval in Liver Cancer
Genoscience Pharma Receives FDA Approval for Phase Ib/IIa Study of GNS561 in Liver Cancer …
Read More
October 20-24, 2017
The AASLD-Liver Meeting 2017
The AASLD - Liver Meeting 2017- Washigton, D.C., USA The American Association for…
Read More
November 11-15, 2016
The AASLD-Liver Meeting 2016
The AALSD-Liver Meeting 2016 - Boston, USA Genoscience Pharma was selected for a…
Read More
June 3-7, 2016
The ASCO Annual Meeting 2016
Even the all-powerful Pointing has no control about the blind texts it is an almost
Read More
February 24, 2016
Four New Members in Our Directory Board
Four New Members in Our Directory Board Marseille, France, February 24, 2016 – Genoscience Pharma…
Read More
November 13-17, 2015
The AASLD-Liver Meeting 2015
The AASLD-Liver Meeting 2015 - San Francisco, USA The American Association for the…
Read More
November 18-21, 2014
The 26th EORTC-NCI-AACR Symposium 2014
The 26th EORTC-NCI-AACR Symposium 2014 - Barcelona, Spain Genocience Pharma was present at…
Read More
February 6, 2012
BL-8030 worldwide License Agreement with BioLineRx
RFS Pharma and Genoscience Pharma enter Worldwide License Agreement with BioLineRx to develop and commercialize Hepatitis…
Read More
January 24, 2012
BL-8020 exclusive License Agreement with BioLineRx
BioLineRx signs exclusive License Agreement for BL-8020, an oral Hepatitis C treatment Jerusalem, Israel,…
Read More
June 19, 2007
Joint Venture Agreement with RFS Pharma
RFS Pharma and Genoscience Pharma Sign Joint Venture Agreement to Discover and Develop Protease Inhibitors…
Read More
